LiquidMate O: One Label for Scalable Item-Level Traceability of Liquid-Filled Medications
Engineered to overcome liquid interference on small, curved pharmaceutical vials—enabling accurate, high-density RFID reads in real-world hospital and pharmacy workflows while supporting scalable, standards-based traceability.
Engineered to overcome liquid interference on small, curved pharmaceutical vials—enabling accurate, high-density RFID reads in real-world hospital and pharmacy workflows while supporting scalable, standards-based traceability.
SAG today unveiled LiquidMate O, its debut RFID label and a category-defining advancement in
pharmaceutical traceability. Built on an innovative, patent-pending antenna design, LiquidMate O
enables reliable item-level RFID tagging of liquid-filled medications under real-world clinical
handling conditions. For more than a decade, liquid interference, curved glass vials, and dense
storage environments have constrained RFID adoption in hospital pharmacies, limiting deployment
to a narrow subset of injectable products.
LiquidMate O is SAG’s most advanced RFID label to date, engineered and independently validated to deliver consistent performance across a broader range of injectable liquid categories that have historically challenged RFID, with performance verified by AXIA Lab using representative liquid formulations defined by actual clinical workflows.
This breakthrough addresses a persistent operational challenge. Ineffective tracking of liquid-filled injectable medications drives millions of dollars in losses each year through expired inventory, misplaced drugs, and compliance exposure. In practice, high-value injectable medications consistently emerge as the most critical targets for RFID adoption, accounting for a disproportionate share of drug spend and carrying elevated clinical and regulatory risk—making reliable, item-level visibility essential.
For pharmaceutical manufacturers, LiquidMate O removes a longstanding barrier to scalable source tagging of injectable vials. Engineered for direct integration into existing labeling and packaging workflows, it enables standards-based, source-applied RFID on liquid-filled glass injectable vials—without formulation-specific labels, line-speed disruption, process changes, or downstream manual tagging, supporting reliable deployment at manufacturing scale.
LiquidMate O is SAG’s most advanced RFID label to date, engineered and independently validated to deliver consistent performance across a broader range of injectable liquid categories that have historically challenged RFID, with performance verified by AXIA Lab using representative liquid formulations defined by actual clinical workflows.
This breakthrough addresses a persistent operational challenge. Ineffective tracking of liquid-filled injectable medications drives millions of dollars in losses each year through expired inventory, misplaced drugs, and compliance exposure. In practice, high-value injectable medications consistently emerge as the most critical targets for RFID adoption, accounting for a disproportionate share of drug spend and carrying elevated clinical and regulatory risk—making reliable, item-level visibility essential.
For pharmaceutical manufacturers, LiquidMate O removes a longstanding barrier to scalable source tagging of injectable vials. Engineered for direct integration into existing labeling and packaging workflows, it enables standards-based, source-applied RFID on liquid-filled glass injectable vials—without formulation-specific labels, line-speed disruption, process changes, or downstream manual tagging, supporting reliable deployment at manufacturing scale.
LiquidMate O
One Label. Real-World RFID Source Tagging Across Injectable Liquids
LiquidMate O is the debut product in the LiquidMate™ solution family, purpose-built to address one of the most persistent barriers in pharmaceutical RFID adoption: reliable item-level tagging of liquid-filled injectable medications. Designed for real hospital and pharmacy environments, LiquidMate O enables accurate RFID tagging directly on small glass vials—where traceability, workflow efficiency, and patient safety matter most.
LiquidMate O
One Label. Real-World RFID Source Tagging Across Injectable Liquids
LiquidMate O is the debut product in the LiquidMate™ solution family, purpose-built
to address one of the most persistent barriers in pharmaceutical RFID adoption:
reliable item-level tagging of liquid-filled injectable medications. Designed for
real hospital and pharmacy environments, LiquidMate O enables accurate RFID
tagging directly on small glass vials—where traceability, workflow efficiency, and
patient safety matter most.
LiquidMate O
One Label. Real-World RFID Source Tagging Across Injectable Liquids
LiquidMate O is the debut product in the LiquidMate™ solution family, purpose-built
to address one of the most persistent barriers in pharmaceutical RFID adoption:
reliable item-level tagging of liquid-filled injectable medications. Designed for
real hospital and pharmacy environments, LiquidMate O enables accurate RFID
tagging directly on small glass vials—where traceability, workflow efficiency, and
patient safety matter most.
SAG Label Solutions
Product Features
Consistent performance across multiple injectable liquid formulations with varying dielectric properties—eliminating formulation-specific RFID label variants, reducing SKU proliferation, and enabling practical, scalable pharmaceutical source tagging.
Validated on industry-standard 10 mL glass vials, featuring a compact 62 × 20 mm label specifically for direct application on space-constrained, curved pharmaceutical vials.
Independently validated by AXIA Lab in real-world pharmacy workflows and simulated logistics environments, delivering 100% read performance in dense, multi-vial configurations, supporting 360° omnidirectional readability.
Fully aligned with GS1 Tagged Item Performance Protocol (TIPP) and Tag Data Standards (TDS), providing a foundation for consistent, standards-based traceability across manufacturing, distribution, and point-of-care workflows.
Through collaboration with industry leaders including RAIN Alliance and GS1, AXIA Lab established real-world field simulations to validate performance. LiquidMate O was rigorously tested under GS1 TIPP protocols, reinforcing readiness for RFID deployment across the pharmaceutical supply chain.
Features
Consistent performance across multiple injectable liquid formulations with varying dielectric properties—eliminating formulation-specific RFID label variants, reducing SKU proliferation, and enabling practical, scalable pharmaceutical source tagging.
Validated on industry-standard 10 mL glass vials, featuring a compact 62 × 20 mm label specifically for direct application on space-constrained, curved pharmaceutical vials.
Independently validated by AXIA Lab in real-world pharmacy workflows and simulated logistics environments, delivering 100% read performance in dense, multi-vial configurations, supporting 360° omnidirectional readability.
Fully aligned with GS1 Tagged Item Performance Protocol (TIPP) and Tag Data Standards (TDS), providing a foundation for consistent, standards-based traceability across manufacturing, distribution, and point-of-care workflows.
Through collaboration with industry leaders including RAIN Alliance and GS1, AXIA Lab established real-world field simulations to validate performance. LiquidMate O was rigorously tested under GS1 TIPP protocols, reinforcing readiness for RFID deployment across the pharmaceutical supply chain.
SAG x AXIA Lab
Advancing pharmaceutical traceability requires more than compliance—it demands real-world validation.
AXIA Lab of Michigan State University is a globally recognized research institute that supports the pharmaceutical and healthcare industries by defining, characterizing, and validating RFID performance using GS1 Tagged Item Performance Protocol (TIPP) methodologies.Through collaboration with AXIA Lab, SAG evaluates LiquidMate O against real-world medication-management conditions, focusing on liquid-filled injectable products that are commonly used, highly regulated, and operationally critical across hospital and pharmacy workflows. AXIA Lab establishes scenario-based test environments and performance benchmarks that reflect actual clinical handling, storage density, and workflow constraints—moving beyond controlled laboratory assumptions.
By aligning LiquidMate O evaluation with these AXIA Lab–defined scenarios, SAG ensures performance is characterized not only in alignment with GS1 standards, but against the liquid formulations and use cases that truly drive item-level traceability in pharmaceutical operations.
By aligning LiquidMate O evaluation with these AXIA Lab–defined scenarios, SAG ensures performance is characterized not only in alignment with GS1 standards, but against the liquid formulations and use cases that truly drive item-level traceability in pharmaceutical operations.
SAG x AXIA Lab
Advancing pharmaceutical traceability requires more than compliance—it demands real-world validation.
AXIA Lab of Michigan State University is a globally recognized research institute that supports the pharmaceutical and healthcare industries by defining, characterizing, and validating RFID performance using GS1 Tagged Item Performance Protocol (TIPP) methodologies.Through collaboration with AXIA Lab, SAG evaluates LiquidMate O against real-world medication-management conditions, focusing on liquid-filled injectable products that are commonly used, highly regulated, and operationally critical across hospital and pharmacy workflows. AXIA Lab establishes scenario-based test environments and performance benchmarks that reflect actual clinical handling, storage density, and workflow constraints—moving beyond controlled laboratory assumptions.
By aligning LiquidMate O evaluation with these AXIA Lab–defined scenarios, SAG ensures performance is characterized not only in alignment with GS1 standards, but against the liquid formulations and use cases that truly drive item-level traceability in pharmaceutical operations.
By aligning LiquidMate O evaluation with these AXIA Lab–defined scenarios, SAG ensures performance is characterized not only in alignment with GS1 standards, but against the liquid formulations and use cases that truly drive item-level traceability in pharmaceutical operations.
Partnership
LiquidMate solutions are built within a robust ecosystem of global standards bodies, technology leaders, and industry alliances. Together, these experts ensure interoperability, performance reliability, and scalability across pharmaceutical supply chains.
AXIA Lab
A research institute at Michigan State University, AXIA Lab supports industry adoption of RFID by defining and validating real-world performance expectations using GS1 TIPP methodologies. Its work focuses on scenario-based evaluation, performance benchmarking, and applied research that inform deployment readiness, including participation in DSCSA-related pilot initiatives.
Impinj
A global leader in RAIN UHF RFID platform technologies, Impinj drives the advancement of RFID ICs, readers, and system architectures that enable high-performance identification at scale. Impinj’s IC innovations underpin dense-reading reliability, long-range performance, and real-world deployability across complex environments—forming a foundational layer for scalable RFID adoption across industries worldwide.
RAIN Alliance
A global organization dedicated to promoting the adoption and interoperability of UHF RFID technology. RAIN Alliance initiatives support the technical alignment necessary for scalable pharmaceutical traceability, including DSCSA-driven and global serialization requirements.
